Prolonged pancytopenia in a gene therapy patient with ADA-deficient SCID and trisomy 8 mosaicism: a case report

A patient with adenosine deaminase–deficient severe combined immune deficiency (ADA-SCID) was enrolled in a study of retroviral-mediated ADA gene transfer to bone marrow hematopoietic stem cells. After the discontinuation of ADA enzyme replacement, busulfan (75 mg/m(2)) was administered for bone mar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Engel, Barbara C., Podsakoff, Greg M., Ireland, Joanna L., Smogorzewska, E. Monika, Carbonaro, Denise A., Wilson, Kathy, Shah, Ami, Kapoor, Neena, Sweeney, Mirna, Borchert, Mark, Crooks, Gay M., Weinberg, Kenneth I., Parkman, Robertson, Rosenblatt, Howard M., Wu, Shi-Qi, Hershfield, Michael S., Candotti, Fabio, Kohn, Donald B.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2007
Teme:
Gene Therapy
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1785101/
https://ncbi.nlm.nih.gov/pubmed/16973956
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2006-06-031476
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items